Aikang Diagnostics Co., Ltd.was founded in August 2013. It is a wholly-owned subsidiary of Aikang MedTech Co., LTD. The company is a high-tech enterprise dedicating to the research and development of in vitro diagnostic reagents(IVD) and supporting equipment, and integrating production, operation and service.

At present, the company has a production office area of more than 6,000 square meters, 100,000 level of clean workshop of 1,500 square meters, has passed the GMP qualification certification and quality system assessment. More than 100 employees, more than 15% of the employees have obtained master degree, more than 85% of the employees have obtained bachelor degree or above, with a professional R&D team and international management platform. The R&D team has rich and powerful experience in in vitro diagnostic reagents (IVD). The company constantly improve the infrastructure and research and development equipment conditions, establishspecialized reagentsresearch and development laboratory, equip with a set of advanced sophisticated research and development equipment.

The company insists on independent innovation. After years of research and development, it has achieved breakthroughs and technological innovations in blood group detection, chemiluminescence, POCT chemiluminescence and immunochromatography. In 2015, blood group detection reagents were developed, and in 2017, various types of in vitro diagnostic reagentssuch as chemiluminescence, POCT chemiluminescence and immunochromatography were launched.

All products are designed and developed in strict accordance with relevant international and national standards, industry standards and market demands, ensuring the safety, reliability and effectiveness of the products.

Shenzhen Aikang Diagnostics Co., Ltd. Is dedicated to leading the enterprise to professional and standardized, make great efforts for human health by providing high quality products and services.